![Aastrom Biosciences, Inc. Logo](/news-release/logo/214280/0/214280.gif?lastModified=12%2F09%2F2016%2023%3A33%3A33&size=2)
Aastrom Biosciences Reports Third-Quarter 2014 Financial Results
13 nov. 2014 08h16 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
![Aastrom Biosciences, Inc. Logo](/news-release/logo/214280/0/214280.gif?lastModified=12%2F09%2F2016%2023%3A33%3A33&size=2)
Aastrom Biosciences to Host Third Quarter 2014 Earnings Call on November 13, 2014
05 nov. 2014 16h30 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
![Aastrom Biosciences, Inc. Logo](/news-release/logo/214280/0/214280.gif?lastModified=12%2F09%2F2016%2023%3A33%3A33&size=2)
Aastrom Biosciences Announces Plans to Change Name to Vericel Corporation and Move Headquarters to Cambridge, Massachusetts
09 oct. 2014 17h30 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
![Aastrom Biosciences, Inc. Logo](/news-release/logo/214280/0/214280.gif?lastModified=12%2F09%2F2016%2023%3A33%3A33&size=2)
Aastrom Biosciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
17 sept. 2014 08h30 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
![Aastrom Biosciences, Inc. Logo](/news-release/logo/214280/0/214280.gif?lastModified=12%2F09%2F2016%2023%3A33%3A33&size=2)
Aastrom Biosciences to Present Three-Year Data From the SUMMIT Extension Study of MACI(TM) at the 2015 American Academy of Orthopedic Surgeons Annual Meeting
16 sept. 2014 08h30 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., Sept. 16, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
![Aastrom Biosciences, Inc. Logo](/news-release/logo/214280/0/214280.gif?lastModified=12%2F09%2F2016%2023%3A33%3A33&size=2)
Aastrom Biosciences Announces Pricing of Public Offering of Common Stock
11 sept. 2014 08h30 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., Sept. 11, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
![Aastrom Biosciences, Inc. Logo](/news-release/logo/214280/0/214280.gif?lastModified=12%2F09%2F2016%2023%3A33%3A33&size=2)
Treatment With Aastrom's Ixmyelocel-T Shown to Reduce Incidence of Major Adverse Cardiovascular Events in Patients With Ischemic Dilated Cardiomyopathy
22 août 2014 09h00 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., Aug. 22, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
![Aastrom Biosciences, Inc. Logo](/news-release/logo/214280/0/214280.gif?lastModified=12%2F09%2F2016%2023%3A33%3A33&size=2)
Aastrom Biosciences Reports Second Quarter 2014 Financial Results
14 août 2014 07h30 HE
|
Aastrom Biosciences, Inc.
U.S. Commercial Business Generates Positive Contribution
Conference Call Today at 8:30 a.m. Eastern Time
ANN ARBOR, Mich., Aug. 14, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc....
![Aastrom Biosciences, Inc. Logo](/news-release/logo/214280/0/214280.gif?lastModified=12%2F09%2F2016%2023%3A33%3A33&size=2)
Aastrom Biosciences to Host Second Quarter 2014 Earnings Call on August 14, 2014
11 août 2014 09h30 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
![Aastrom Biosciences, Inc. Logo](/news-release/logo/214280/0/214280.gif?lastModified=12%2F09%2F2016%2023%3A33%3A33&size=2)
Aastrom Announces Appointment of Zac Taylor as National Sales Director
14 juil. 2014 08h30 HE
|
Aastrom Biosciences, Inc.
ANN ARBOR, Mich., July 14, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...